Home > Formulary : Adult > Recent Decisions > 2023 >
Decisions 21st March 2023
New Drug Requests
Approved
Ivermectin (oral) (TLS Red)
-
For treatment resistant scabies, specialist use only, not for children under 15kg.
Hydrocortisone sodium phosphate 3.35mg/mL eye drops (Softacort) (TLS Red)
-
For short-term treatment of mild non-infectious allergic or inflammatory conjunctival diseases for patients who are at increased risk of raised intraocular pressure and who require a preservative-free option.
Shared Care Protocols
Nil
Traffic Light Status Change Requests
-
Cenobamate to be changed from TLS Red to TLS Amber Specialist Initiated.
-
Insuman Basal to be changed from TLS Green to TLS Blue for existing patients only
-
Insuman Comb 25 to be changed from TLS Green to TLS Blue for existing patients only
-
Humulin M3 to be changed from TLS Blue to TLS Green
-
Insuman Rapid to be changed from TLS Green to TLS Blue for existing patients only
-
Humulin S to be changed from TLS Blue to TLS Green
-
Entacapone and entacapone in combination with levodopa and carbidopa to be changed from Amber 1 month to Amber Specialist Recommended.
-
Dabigatran and edoxaban for treatment and prevention of recurrent DVT and PE to be changed from Amber 1 month to Green.
-
Oral amiodarone to be changed from TLS Green to TLS Amber and for there to be further review as part of the cardiodlogy chapter review.
-
Betamethasone soluble tablets, dexamethasone soluble tablets (oral rinse) and fluocinolone acetonide 0.025% gel (Synalar®) (oral) to be changed from TLS Amber 1 month to TLS Amber Specialist Recommended.
-
Ferric Maltol to be changed from Amber 1 month to Amber Specialist Initiated.
-
Midodrine for orthostatic hypotension to be changed from Amber 1 month to Amber Specialist Initiated.
-
Pramipexole for PD to be changed from Amber 1 month to Amber Specialist Initiated.
-
Pregabalin for seizures to be changed from Amber 1 month to Amber Specialist Initiated.
-
Rasagiline for PD to be changed from Amber 1 month to Amber Specialist Initiated.
-
Ropinirole for PD to be changed from Amber 1 month to Amber Specialist Initiated.
-
Cabergoline for PD to be changed from Amber 3 months to Amber Specialist Initiated (existing patients only).
Gastroenterology Chapter Review Decisions
-
Famotidine and nizatidine to be changed from TLS Amber no SCP to TLS Green when a PPI is not appropriate or unless specialist recommended.
-
Bismuth chelate (for treatment of H Pylori eradication) to change from TLS Blue to TLS Amber Specialist Recommended.
-
Lansoprazole to be changed from TLS Blue to TLS Green
-
Eluxadoline to be removed from the formulary as this has been discontinued.
-
Ranitidine to be removed from the formulary as this has been withdrawn from the market.
-
Pancrex to be changed to Pancrex V to reflect brand name change.
-
Colestipol to be removed as this has been discontinued.
Other Formulary Decisions
-
Changes to Amber Traffic Light categories and definitions were agreed:
- Amber 3 month and 1 month - no change
- Amber No SCP renamed as Amber Specialist Recommended
- New category - Amber Specialist Initiated.
-
Changes to the New Drug Request Application paperwork were agreed including removal of short forms. A single New Drug Request form to be used going forward.
-
Insuman insulins are being discontinued. These will be removed from the Joint Formulary when supplies are exhausted.
-
Isotretinoin to be changed from TLS Red 'hospital consultant only' to TLS Red 'restricted to dermatology specialist teams only'.
-
Removal of SCP and separate entry for exenatide in combination with insulin. TLS of exenatide with/without insulin to be blue.
-
Removal of alfacalcidol and rotigotine prescribing guidance, sulfasalazine monitoring guidance, naltrexone agreement forms and Collistin trial information as no longer required.
-
Confirmation that the TLS of haloperidol injection in chapter 4.2 is TLS Amber 1 month - SCP to be developed.
-
Confirmation that the TLS of namlefene in Bristol is TLS Amber Specialist Recommended.
-
Confirmation that the TLS of goserelin (Zoladex) for breast cancer is TLS Amber 3 months.
-
Confirmation that the TLS of carbamazepine for bipolar disorder and mania should be Amber Specialist Initiated